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The number of protein containing therapeutic drugs is growing day by day. Lack of
proper storage conditions can cause protein degradation or aggregation.
The osmotic second virial coefficient, B22 , is a thermodynamic parameter, which can
predict protein interaction with other proteins and solvent molecules. B22 has been successfully used as predictor of crystallization conditions for a protein in the solution, and in
this study an attempt has been made to relate B22 as a predictor of stability of the protein.
Static light scattering was used to measure B22 in our studies. B22 and the solubility of
three proteins were measured in several excipient solutions. George et al. in 1997 related
the osmotic second virial coefficient with the solubility of protein in a solution [9]. In this
study we have attempted to relate solubility with B22 and stability of lysozyme, human
serum albumin, and ovalbumin in buffer solutions containing various excipients.
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CHAPTER I
INTRODUCTION
1.1 Motivation
The number of protein-containing therapeutic products is growing. The main issues in developing these products are shelf life / stability and solubility. The protein formulation products, when used for medicinal purposes, should be safe to use and physically,
chemically, and biologically stable [4]. Products that are unstable may be denatured, and
become aggregated. If these products do not meet safety standards, administration of such
products may be deleterious.
Proteins in a body exist in a surrounding environment of complex cosolvents. To find
a solution in which proteins used for medicinal purposes are stable, and administrable is
very difficult [5]. Maintaining protein conformation and colloidal stability is difficult
because, the proteins are marginally stable, and susceptible to both physical and chemical
degradation [6].
Timasheff and his coworkers [7] have dedicated several years to understanding the
role of cosolvents in the complex protein-water-cosolvent induced interaction. Choosing
a proper cosolvent is the key for obtaining a stable protein formulation. But choosing a
cosolvent, which could induce protein stability, is a difficult task.
1
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The osmotic second virial coefficient (B22 ) is a thermodynamic parameter that predicts
the extent of protein interaction with other protein and solvent molecules in a dilute solution [5, 8, 9, 10]. It is believed that at negative B22 values the intermolecular forces are
attractive, and they are repulsive when B22 values are positive. B22 accounts for contributions from electrostatic,van der Waals interactions, excluded volume, hydration forces,
and hydrophobic effects. These parameters play important roles in protein stability and
solubility [5, 8-10].
Static light scattering (SLS) has been historically used for measuring B22 values of
protein solutions. Wilson and coworkers have pioneered the area of measuring B22 values
for proteins using static light scattering methods [8-15]. The primary requirement for performing B22 measurements using SLS includes dilute protein solutions with concentration
ranging from ∼ 1 to 7 mg/mL [10-12]. In this age, when nanotechnology is advancing,
this amount is considered to be large, and several efforts have been made to reduce the
amount of sample required for measuring B22 . Self-interaction chromatography (SIC) is
an upcoming technique used for measuring B22 . Advantages offered by this method will
be realized in the coming decade [11, 12].
In this study we have used SLS as a tool for measuring B22 for lysozyme, ovalbumin,
and human serum albumin (HSA) in the presence of cosolvents such as NaCl, ammonium
sulfate (AS), sucrose, trehalose, glucose, mannitol, and dextran150.

3
The main objective is to show that the addition of cosolvents or excipients to the protein
solution increases B22 , which leads to increased stability of the protein in that solution.
This can be rationalized in terms of increased protein solubility.

1.2 Protein Stability
If in a particular solution condition the protein maintains its native conformation,
and is colloidally stable then it is said to be stable. Protein stability can also be defined
as avoiding “denaturation” and “aggregation”. “Denaturation is disorganization of the
natural protein molecule, the change from the regular arrangement of a rigid structure
to the irregular, diffuse arrangement of the flexible open chain” [13]. Aggregation takes
place when two protein molecules come close to each other, and their hydrophobic patches
join together. Aggregation can be of two types (1) the protein molecules come together,
and form long chains in an irregular manner, resulting in amorphous precipitates also
known as “praggs”, and (2) the protein molecules come together in an orderly fashion,
and form crystals, also known as “craggs” [14]. Both biologically active (native state)
and biologically inactive protein molecules can be involved in precipitation, while only
biologically active proteins are involved in crystallization.
Protein stability accounts for both colloidal stability and conformational stability of the
protein in the surrounding environment [15]. In this study, emphasis is given to colloidal
stability of the proteins. Thermodynamically, conformational stability of a protein’s native
state can be given in terms of free energy. The free energy of native conformation is only
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5-6 kcal/mol less than the free energy of non-native conformations which are biologically
inactive [6, 7]. The balance between large stabilizing forces and large destabilizing forces
results in this net conformational stability. The free energy of folding arises due to contributions from electrostatics (charge repulsion and ion pairing), hydrogen bonding, van der
Waals interactions, and hydrophobic interactions [6, 7].
The osmotic second virial coefficient (B22 ) predicts the colloidal stability of the protein
in a particular solution condition. B22 accounts for both short and long range interactions,
such as electrostatic interactions, van der Waals interactions, excluded volume, and hydrophobic interactions. [5, 13].
A positive B22 indicates that the protein-protein interactions are repulsive; consequently, in a solution the protein molecules stay apart from each other, and prevent crystallization and aggregation. Crystallization and aggregation require the protein molecules
to come together to from a nucleation center [9-12, 17] In other words, a positive B22 indicates that the protein in a solution is colloidally stable. A negative B22 suggest attractive
protein-protein interactions, a condition favorable for crystallization/ aggregation. Thus
the solutions for which, B22 values are negative are said to be colloidally unstable [9-12,
16].
External variables like temperature, pH, salt, cosolvents, surfactants, etc. can cause
denaturation and aggregation of the proteins by altering the extent of the above-mentioned
interactions. Any change in interactions will cause a change in the free energy of unfolding
and in B22 [6, 7, 16, 17].
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1.3 Effects of External Variables on Protein Stability
Protein stability is affected by external variables such as temperature, ligands and
cosolvents, pH of the solution, preservatives and surfactants. We will take a detailed look
at each of these factors in the following subsections.

1.3.1 Temperature
The role of temperature in protein stability is complex and controversial, though it
is clear that it has a significant effect on the conformational and chemical stability of the
protein. At high (e.g., 50◦ C − 100◦ C) and low (e.g., less than 10◦ C) temperatures the free
energy of unfolding (△G◦unfold) becomes negative, suggesting that denaturation/unfolding
of the protein will occur [4, 6, 7].
Hydrophobic effects are considered to be the primary cause of thermal denaturation.
Increase in temperature increases the entropy of the solution, which causes unfolding of
the protein molecules. Exposed hydrophobic patches of unfolded protein molecules join
together, and aggregation takes place. Hydrophobic effects weaken at low temperature,
due to increased solvation of hydrophobic groups. As a result, dissociation of the proteins
containing subunits takes place, resulting in its denaturation [4, 6, 7].

1.3.2 Ligands and Cosolvents
The protein in a solution is in equilibrium between its native conformation and
its non-native conformation. Ligands and cosolvents, when added to the solution, shift
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the equilibrium towards native or non-native conformations. Ligands such as polyanions
effect the protein stability by binding to the native state, and shift the equilibrium toward
the native state. However, binding of polyanions alters the structure of the protein, and
renders it of no use for the desired medicinal purposes.
Sugars, polyols, and denaturants interact weakly with the native and the non-native
conformation [4, 18, 19]. It is known that sugars and polyols are preferentially excluded
from the surface of the protein, and hence the proteins are preferentially hydrated. Addition of sugars and polyols increase the surface tension of water, resulting in exclusion of
additives from the water-protein interface. Since this is a high-energy state according to
the Le Chatelier’s principle, the system should reduce its energy by adopting a low energy
state, which is obtained by minimizing the area of the water-protein interface. As a result, the protein adopts the more compact native conformation, and the equilibrium shifts
towards native conformation on addition of such additives [18, 20, 21].
Denaturants do exactly the opposite, and bind preferentially to the unfolded state. This
shifts the equilibrium towards the non-native conformation causing the protein denaturation [6].

1.3.3 The pH of the Solution
Protein stability largely depends on the pH of the solution, which imparts the
overall positive or negative charge on the protein molecules, thus affecting electrostatic interactions. At extreme pH, non-specific electrostatic repulsion results due to the presence

7
of charged groups on the protein molecules. This disturbs the folded conformation due
to the increase in charge repulsion within the protein molecule. An increase in the number of charged groups also gives rise to specific charge interactions, such as salt bridges
(i.e., ion-pairing), which leads to conformational stability. At the isoelectric point where
there are equal numbers of positive and negative charges on the protein, increase in dipole
moment takes place, which makes the protein-protein interaction attractive leading to aggregation. The protein-protein interactions are repulsive when the protein molecules are
highly charged, which stabilizes the protein solution [6, 22, 16].

1.3.4 Preservatives
Preservatives are required to prevent bacterial growth in the protein formulations
used for medical purposes. Preservatives like phenol, m-cresol, and benzyl alcohol are
known to cause the protein aggregation. The phenomenon by which these preservatives
cause aggregation is still unknown, and requires more research work to be done [6].

1.3.5 Surfactants
Surfactants adsorb at air/water and solid/water interfaces reducing the adsorption
of the protein, and interface induced aggregation. These surfactants can bind preferentially
to the unfolded state, resulting in reduced protein stability, or can bind to the folded state,
increasing protein stability [6].
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1.4 Thermodynamics of Protein Stabilization
In a solution, the proteins exists at equilibrium between the (1) Native (biologically
active) and (2) Non-Native denatured (biologically inactive) conformation.

Keq

N ⇀
↽ D

(1.1)

where Keq is the equilibrium constant and is defined as
Keq =

[D]
[N]

(1.2)

The extent to which the protein will maintain its native conformation is given by
△G◦unfold which is defined as
△G◦unf old = −RT lnKeq

(1.3)

The colloidal stability that consists of repulsive and attractive interactions between the
protein molecules is measured by the osmotic second virial coefficient (B22 ) [13, 20, 23].
The addition of excipients that cause a decrease in △G◦unfold , decreases the conformational stability of the protein. Urea, alcohols, amides, formamides, guanidium salts,
glycols, sodium dodecyl sulfate, etc. are a few examples of destabilizers. On the other
hand, excipients that increase the △G◦unfold, increases conformational stability.
Excipients like sugars, polyols, amino acids, polymers, etc. are known to increase
△G◦unfold, hence they are used as stabilizing agents.
Another way to explain the same phenomenon is in terms of preferential exclusion or
negative binding of excipients to the proteins. Stabilizers are preferentially excluded from
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the protein surface because addition of stabilizers to the solution is found to be thermodynamically unfavorable. The addition of stabilizers increases the surface tension of the
water, which results in exclusion of stabilizers from the protein-water interface. Since this
is thermodynamically unfavorable, the system reduces its energy by adopting a more compact geometry and avoids expansion of the protein molecules, which would increase the
surface free energy of the water. Thus, the overall process favors the native state, that is
less exposed to solvent, and is thermodynamically preferred.
It is a very well established fact that addition of excipients like sugars, polyols etc.,
conformationally stabilize the protein in a solution [5, 6, 16, 20, 22, 23, 25-28]. Much
work has been done showing that addition of stabilizers increases the conformational stability, but not much work has been done to see what effect addition of stabilizers have
on the colloidal stability. In this study we have measured the effect of excipients on the
colloidal stability of the protein in the solution by measuring B22 in solution using light
scattering methods.

1.5 The Second Virial Coefficient (B22 )
The Second virial coefficient is a dilute solution parameter, which gives the extent
of the protein-protein interactions. There are three common ways in which the second
virial coefficient is determined, namely osmometry, static light scattering (SLS), and selfinteraction chromatography (SIC) [24].
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Osmometry works on the principle, that a difference in osmotic pressure will exist
between two solutions separated by a semipermeable membrane. In the case of ideal
solutions the osmotic pressure is given by van’t Hoff’s law as
RT
π
=
c2
M2

(1.4)

For a dilute solution of macromolecules, the osmotic pressure is given by the virial
expansion of van’t Hoff’s Law given as
π
RT
=
+ B22 RT c2 + . . .
c2
M2

(1.5)

where,
• π = the osmotic pressure.
• c2 = concentration of the protein/solute (g/mL).
• R = the gas constant (8.314 J/k.mol).
• T = temperature (K).
• M2 = molecular mass (g/mol).
• B22 = the osmotic the second virial coefficient (mol.mL/g2).
The contribution from higher order terms is small, and generally are negligible. If
we plot

π
c2

versus c2 , the intercept of the plot is

RT
,
M2

so that the molecular weight of the

molecule can be determined. From the slope (B22 RT) the second virial coefficient can be
determined. An example plot of

π
c2

versus c2 is shown in Figure 1.1 for various protein

solutions [1].
The second approach used to determine B22 is by using static light scattering (SLS).
This method requires less protein than that required for osmometry. In this method the
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light scattered due to the protein molecules in excess of background (i.e., solvent, crystallizing agent, excipient, or dust particles) is measured as a function of increasing protein
concentration [8-15, 17]. The data acquired are interpreted by the working equation given
by Kratochvil as [10]

1
Kc
=
+ 2B22 c
R90
M

(1.6)

where K is an optical constant given by
K=

4π 2 η◦2



NA

dn
dc
λ4

2

(1.7)

• c = protein concentration (g/mL).
• η◦ = refractive index of the solvent.
•

dn
dc

= the refractive index increment.

• NA = Avogadro’s number (6.023 × 1023 mol−1 ).
• λ =wavelength of incident light (nm).
R90 is the Rayleigh factor at a scattering angle of 90◦ measured as a function of protein
concentration.
It can be seen from Eq. (1.7), if we plot Kc/R90 versus c, a straight line is obtained.
The intercept of this straight line (1/M) gives the molecular weight of the protein, and its
slope (2B22 ) gives B22 of the protein in that particular solution.
The third method used to determine B22 is self-interaction chromatography (SIC),
which is a fairly new technique [6, 12]. This method requires a smaller amount of protein
when compared to osmometry and SLS.
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The extent of intermolecular interaction in the protein-water-cosolvent system can be
judged by the obtained B22 values. If negative B22 values are obtained the intermolecular
attractions are attractive, i.e at high negative values the proteins will come together to
form aggregates or precipitate, and the solution is said to have “crashed”. At moderately
negative B22 values the protein-protein interactions are attractive, and protein crystals may
be obtained. The solvents in which negative B22 values are obtained are referred to as
“poor” solvents [8, 10, 25, 26].
The protein-water-cosolvent system is said to be at a “Theta” state when B22 is zero.
At this state there is no net intermolecular attraction or repulsion. This solution is said to
be an “ideal” solution [8, 10, 25, 26].
Positive B22 values indicate net repulsive intermolecular forces. It is observed that as
B22 becomes more positive, the solubility of the protein in that solution increases when
compared to solubility of the protein in solution with negative B22 . The solvent is referred
as a “good” solvent when it has positive B22 values [5, 7-9].

1.6 Solubility (S)
In terms of chemical potential, solubility can be defined as the concentration of
the protein in a solution when the system is at equilibrium between the two phases, i.e the
crystalline phase/amorphous phase and the solution phase [26, 27].
µ2 (sol) = µ2 (xtal)

(1.8)
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Knowing the solubility of a protein in a particular solution works to our advantage. To
study the structural properties of the protein, crystals are required. To get good crystals a
saturated protein solution is required, which can be made easily if the solubility is known
[24].
Solubility can also play an important role when searching for a suitable solvent for
developing a stable protein formulation. Avoiding saturation while developing a stable
protein formulation is important to minimize crystallization/aggregation.
Determining solubility is not easy and is labor intensive. Solubility data for most of
the proteins besides lysozyme, horse serum albumin, and concanavalin A do not exist in
available literature [9].

1.7 Correlation between S and B22
George et al. developed a correlation between solubility and the second virial
coefficient in 1997 [8, 10, 25, 28]. They determined B22 values for horse serum albumin
using SLS in 50 mM sodium acetate with 45 % (w/v) saturated ammonium sulfate (SAS)
at pH 5.5 at temperatures ranging from 10◦ C to 25◦ C and compared it with available
solubility data. A systematic trend was observed between horse serum albumin solubility
and the second virial coefficient. In the same study, B22 for lysozyme in 100 mM sodium
acetate with 2.5 % (w/v) sodium chloride at pH 4.2 at temperatures varying from 10◦ C to
20◦ C were measured and than compared with available solubility data, a correlation was
found between B22 and S values [9].
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In 1999, Guo et al. measured B22 for lysozyme and ovalbumin in about 20 different
solution concentrations [10]. Solubility at these conditions from the literature was then
compared with B22 to make sure that a correlation existed between B22 and S values. This
study led to the development of a theoretical model relating B22 and S, known as the
Haas-Drenth-Wilson model [25].
Another study was done in 2002; Demoruelle et al. measured B22 and S values for
Equine Serum Albumin (ESA) using SLS and the sitting drop method. A plot of B22
versus S was made and a good correlation existed between these values [26].
From these studies the conclusion was drawn that the dilute solution parameter (B22 )
indicates the behavior of a protein at saturation. Thus B22 can be used to predict the
solubility behavior of the protein in a particular solution [9].

CHAPTER II
EXPERIMENTAL
Static light scattering (SLS) was used to measure the second virial coefficient ( B22 )
values for Lysozyme, Human Serum Albumin (HSA), and Ovalbumin (purchased from
Calbiochem) in buffer solution containing various excipients such as sodium chloride,
ammonium sulfate (AS), mannitol, trehalose, sucrose, glucose, and dextran150. Solubility of the lysozyme was then estimated in the same buffer solution containing different
excipients.

2.1 Lysozyme
Lysozyme is a globular protein, having a molecular weight of 14.4 kDa and a
diameter of 4 nm. Lysozyme is obtained from hen egg white and was discovered by
Alexander Fleming during a search for medical antibiotics in 1922 [24]. It is known that
lysozyme is effective against bacterial infections since it destroys the structural integrity of
the bacterial cell wall. Lysozyme in hen egg white protects the proteins and fats that feed
the developing chick in the egg. Much research has been done on lysozyme and sufficient
physical and chemical information is available for lysozyme compared to other proteins.
Hence, lysozyme is used as model protein for most protein related studies.
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2.2 Ovalbumin
Ovalbumin is a glycoprotein found in egg white. It protects the egg yolk and nurtures developing baby in the egg. It has an approximate molecular weight of 45 kDa.

2.3 Human Serum Albumin
Human serum albumin is a protein found in the human blood plasma. It is produced in the liver and has an approximate molecular weight of 67 kDa. Low levels of
albumin in blood leads to malnutrition, liver disease, nephritic syndrome, etc.

2.4 Excipients
Excipients can be defined as cosolutes or additives, which interact weakly with the
protein molecules causing an increase or decrease in protein stability. Ligands, salts, sugars, and polyols are a few examples of excipients. The protein in an ideal solution should
exist at equilibrium between the native and the non-native protein conformation. Addition of excipients to the protein solution can either shift the equilibrium towards the native
conformation, which would stabilize the protein in that particular solution, or it could
shift the equilibrium towards the non-native conformation, and lead to the aggregation or
denaturation of protein in that particular solution condition [6, 18, 29].
Excipients used in this study include sodium chloride (NaCl), AS, mannitol, glucose,
trehalose, sucrose, and dextran150.
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2.4.1 Sodium Chloride (NaCl)
Salt can interact in several ways with the protein molecule depending on the pH
of the solution and the salt concentration. Different types of salts have different effect
on the protein stability and solubility in a particular solution. Salt at low concentration
shields the charge on the protein molecule, causing a decrease in electrostatic interactions,
which results in conformational stability and colloidal stability. At high concentrations
of salt, binding of salt ions with the protein takes place, which can increase electrostatic
repulsion within the molecule, and can lead to unfolding of the molecule, which results in
protein denaturation, and disrupts the colloidal stability. The overall charge on the protein
molecule is dictated by the pH of the solution; hence the effect of salt on the protein in a
particular solution is highly pH dependent [4, 6, 7, 16, 17, 30].

2.4.2 Ammonium Sulfate (NH4 )2 SO4
Ammonium sulfate, also known as Mohrs salt, is a commonly used fertilizer. It
is acidic in nature, and its addition to soil maintains the pH balance of the soil. It is a
commonly used reagent for precipitating proteins out of the solution. It has a molecular
weight of 132 g/mol.

2.4.3 Mannitol, Glucose, Trehalose, and Sucrose
Mannitol (a) is a polyol having molecular weight of 182 g/mol.
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Glucose (b) is a monosaccharide and has an empirical formula C6 H12 O6 and a molecular weight of 180 g/mol. It is a common sugar found in plants and animals, and is the
major source of energy in animal metabolism. Glucose has been used to stabilize the
proteins, and due to its ease of digestion and administration, it is a sugar of interest for
pharmaceutical companies.
Sucrose (c) is a disaccharide made up of two molecules, namely glucose and fructose.
having a molecular weight of 342 g/mol. It is a commonly used sweetener, is used widely
in the pharmaceutical industries for maintaining the activity of the protein molecules, and
is effective against denaturation of the proteins used for medical purposes.
Trehalose (d) is a disaccharide made up of two glucose molecules. It has a molecular
weight of 378 g/mol, and is extensively used for maintaining the activity of the protein
during freeze-drying. Structural formulas of the sugars used are shown in Figure 2.1.
The exact phenomenon by which these sugars stabilize the proteins in aqueous solution is controversial and complicated. After spending more than a decade researching the
mechanism by which these cosolutes affect the stability of the protein molecules, Timasheff and coworkers [29] concluded that these excipients are preferentially excluded from
the surface of the protein molecules due to increased surface tension resulting in hydration
of the protein. In terms of free energy, it can be said that the free energy of unfolding
is increased upon addition of these excipients; hence the native or folded state is favored
over the unfolded state.
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2.5 The Static Light Scattering Method for B22 Measurement
A commonly used method to measure B22 , which is a thermodynamic parameter
related to the protein interactions with other protein and solvent molecules, is static light
scattering (SLS).
Materials used and their sources are as follows: Hen egg white lysozyme (Calbiochem,
Lot # B58915), ovablumin (Calbiochem, Lot # B60780), human serum albumin (Calbiochem, Cat # B65145), sodium chloride (Sigma Lot # 942836), sucrose (Sigma, Lot #
90H0679), mannitol (Sigma Lot # 023K0178), trehalose (Sigma Lot # 114K7020), ammonium sulfate (Fisher Scientific, Lot # 991875A), sodium phosphate monobasic (Fisher
Scientific, Lot # 912830A), sodium phosphate dibasic (Fisher Scientific), glacial acetic
acid 99.7 % (Fisher Scientific, A38), sodium hydroxide 97 % ( Fisher Scientific), sodium
azide (Fisher Scientific). Dionized water used for experimental purposes was prepared
using a QUANTUM EX ultrapure organex cartridge (Millipore).
Experiments with lysozyme were carried out in sodium acetate buffer, which was prepared by weighing 6 g of glacial acetic acid into a 1 L beaker containing ∼ 800 mL of
DI water and adding 50 g of NaCl to make a 0.1 M NaAc buffer with 5 % (w/v) NaCl.
The solution was titrated against 0.1 M NaOH to adjust the pH to 4.5 and then filled to
the 1 L mark in a volumetric flask. To prevent bacterial growth, 0.05 % w/v sodium azide
(NaN3 ) was added to the buffer. Buffer solutions with different excipients were prepared
by adding the appropriate amount of the excipient into a volumetric flask of desired volume and slowly adding 0.1 M NaAc buffer with 5 % (w/v) NaCl and 0.05 % (w/v) NaN3
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so that all the excipients were properly dissolved and then filled to the mark. This buffer
solution was then filtered using a 0.45 µm Millipore filtration system.
Lysozyme stock solution was prepared by dissolving lysozyme into the buffer solution
containing excipient. Dissolving this protein into buffer was difficult due to lower solubility at room temperature; hence it was dissolved in a 40◦ C water bath. The stock solution
was filtered manually with a syringe using 0.22 µm, 4 mm Millex Millipore disposable
filters, and the final concentration was determined spectrophotometrically using A (1 %, 1
cm, 280 nm) = 26.3 for lysozyme [7].
Experiments with ovalbumin were performed in 0.1 M sodium phosphate, pH 7.0
buffer. Sodium phosphate buffer was prepared by weighing 13.5 g of sodium phosphate
monobasic into a 1 L beaker containing ∼ 800 mL of DI water and 0.05 % (w/v) sodium
azide to prevent bacterial growth and weighing 14.9 g of sodium phosphate dibasic in a
separate beaker containing ∼ 800 mL of DI water. Each solution was transferred into a
separate 1 L volumetric flask and filled to the mark. Then ∼ 500 mL of sodium phosphate
dibasic was titrated with sodium phosphate monobasic until the desired pH was obtained.
Ovalbumin was purified by preparative size exclusion chromatography. Monomer fractions were collected and concentrated using an Amicon 8010 concentrator with a Millex
Millipore membrane, 42 mm, Molecular weight cut off 3,000 g/mol. The stock solution
was filtered with a syringe using 0.22 µm, 4 mm Millex Millipore syringe filters. The
stock concentration was determined spectrophotometrically using A (1 %, 1 cm, 280 nm)
= 7.0 for ovalbumin [7].
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Human serum albumin experiments were carried in 0.1 M sodium phosphate buffer,
2.6 M AS at pH 7.0. Sodium phosphate buffer was prepared as described earlier and appropriate weight of AS was added to make final AS concentration to be 2.6 M. HSA was
purified and concentrated as mentioned for ovalbumin. Stock concentration was determined spectrophotometrically using A (1 %, 1 cm, 280 nm) = 5.3 for HSA [9].
The second virial coefficient was measured by Right Angle Laser Light Scattering
(RALLS) Detector model 600 (λ = 670 nm) from Viscotek. In this method, the average
intensity of light scattered by a protein solution of four to five known concentrations is
measured in excess of that scattered by background sources such as solvents, excipients,
salts, stray light, etc. A block diagram of the SLS setup is shown in Figure 2.2.
The data obtained is analyzed using the working equation given by Kratochvil as described in chapter 1.

2.6 The Solubility Measurement for Lysozyme
The solubility of lysozyme was estimated in 0.1 M NaAc, 5 % (w/v) NaCl, pH 4.5
buffer, 0.05 M, 0.2 M, 0.25 M and 0.3 M mannitol in 0.1 M NaAc, 5 % (w/v) NaCl buffer
at pH 4.5, 0.1 M, 0.2 M, 0.3 M, 0.4 M and 0.5 M trehalose in 0.1 M NaAc, 5 % (w/v)
NaCl buffer at pH 4.5; and in 0.1 M, 0.2 M, 0.3 M, 0.4 M and 0.5 M sucrose in 0.1 M
NaAc, 5 % (w/v) NaCl buffer at pH 4.5.
Lysozyme stock solutions were prepared in the above mentioned buffers. Supersaturated stock solutions were prepared to obtain phase separation because solubility is defined

Detector
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Figure 2.2
Block diagram of a light scattering instrument
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as the protein concentration at which the solution is at equilibrium between the protein in
the solution phase and the protein in crystalline phase or amorphous phase. Protein was
dissolved in the buffer solutions at room temperature, and then incubated at 25◦ C for 48
hours. Before measuring the concentration of the protein spectrophotometrically the tubes
containing protein and amorphous precipitate were centrifuged at 6,000 rpm for 20 minutes, and then 30-50 µL of supernatant was diluted, and the absorbance was measured at
280 nm. The obtained solubility values are reported in the results section .

CHAPTER III
RESULTS AND DISCUSSION
Predicting protein stability in a particular solution condition is a sensitive issue. With
the increasing number of protein therapeutic products in the market, an effective way to
determine protein stability should be developed. According to Krishnan, et al [23] protein
stability consists of (1) conformational stability and (2) colloidal stability of the protein in
the solution [13, 20, 23]. To develop a stable protein formulation both conformational and
colloidal stability of the protein in the solution should be achieved. The conformational
stability is measured by (△G◦unfold) and the colloidal stability is measured by the osmotic
second virial coefficient (B22 ) in a solution [13].
In this study, the effect of addition of excipients to the protein solution on the colloidal
stability, i.e., stability of the protein in a solution in terms of crystallization and aggregation, is measured and the results are presented in the following sections.

3.1 B22 Measurement for Lysozyme in Buffer Containing Cosolvents
The second virial coefficient B22 was measured for lysozyme monomer. Lysozyme
was dissolved in a 0.1 M NaAc, 5 % (w/v) NaCl, pH 4.5 buffer and filtered into quartz
cells of volume 45 µL or 12 µL and dynamic light scattering (DLS) experiments were
performed to check for the presence of oligomers like dimers, trimers, or aggregates and
26
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dust particles. Figure 3.1 shows the percentage intensity of light scattered by each species
present in the solution.
The presence of only lysozyme monomer, having an average hydrodynamic radius of
1.8 nm is shown in Figure 3.1. The molecular weight estimated from the Rh value was ∼
14 kDa, calculated using
D=

Γ
q2

(3.1)

where, D (cm2 /s) is the diffusion coefficient, Γ (s−1 ) is the decay constant obtained
from the correlation function, q2 is the magnitude of the scattering vector, given as

q=

4πη◦
λ◦ sin( 2θ )

(3.2)

where η◦ is the solvent refractive index, λ◦ is the vacuum wavelength of the incident
light, and θ is the scattering angle.
Using the Stokes-Einstein equation, the hydrodynamic radius can be calculated
Rh =

kT
6πηD

(3.3)

where k is Boltzmann’s constant, T is the temperature in Kelvin, and η is the solvent
viscosity (cm3 /g).
From the hydrodynamic radius, the molecular weight of the protein can be estimated
using the empirical relationship developed from years of work in Wilson’s lab:

Rh
M=
4.9 × 10−2


2.64

(3.4)
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Figure 3.1
DLS histogram for lysozyme
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where M is the molecular weight of the protein and Rh is in nm.
The DLS results confirmed that no further purification of the commercial lysozyme
was required other than membrane filtration to remove dust.
Static light scattering (SLS) was used to determine B22 for lysozyme. Right Angle
Laser Light Scattering was used for performing light scattering experiments. Protein solutions of several known concentrations ranging from ∼ 1- 8 mg/mL were injected directly
into a 10 µL scattering cell using the “SIPPER” method. In this method protein solution
in a small well is sipped into the cell with the help of peristaltic pump. All the solutions
were filtered using 0.22 µm, 13 mm Millex Millipore disposable filter.
The light scattering profile of the buffer (baseline) and five different lysozyme concentrations is shown in Figure 3.2. The lysozyme stock solution was diluted to give protein
concentrations ranging from 1 mg/mL to 5 mg/mL. The solutions were injected starting
from lower concentration to higher.
From the intensity of the light scattered by buffer (background) and the light scattered
by the protein solutions going from lower to higher concentration, B22 can be calculated
based on Eq. (1.7). A plot of

Kc
R

versus c is shown in Figure 3.3. The slope of the line

gives B22 as −7.2 × 10−4 (mol.mL/g2 ).

3.1.1 B22 and Solubility Measurement for Lysozyme in Buffer Containing Sucrose
The second virial coefficient of lysozyme was measured in 0.1 M NaAc, 5 % (w/v)
NaCl, pH. 4.5 containing different sucrose concentrations. Figure 3.4 shows the

Kc
R

versus
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Figure 3.2
Light scattering profile of lysozyme in 0.1 M NaAc, 5 % (w/v) NaCl, pH 4.5
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lysozyme concentration, c, in 0.1 M NaAc, 5 % (w/v) NaCl, pH 4.5, 25◦ C at 0.0, 0.1, 0.2,
0.3, 0.4, and 0.5 M sucrose. The tabulated B22 values in Table 3.1 were calculated from
the slopes of the plots in Figure 3.4.
B22 values increased with increasing sucrose concentration ranging from −7.2 × 10−4
at 0.0 M sucrose to −0.7 × 10−4 (mol.mL/g2 ) at 0.5 M sucrose. At 0.0 M sucrose,
B22 value of −7.2 × 10−4 (mol.mL/g2 ) suggests that the protein-protein interactions are
attractive. At the maximum sucrose concentration studied here B22 value increases to
−0.7×10−4 (mol.mL/g2 ), which means that the protein-protein interactions have become
less attractive. A plot of B22 versus sucrose concentration is shown in Figure 3.5. The data
points in Figure 3.5 represent average of at least two B22 values, and error bars represent
standard deviations of the average B22 values.
B22 values listed in Table 3.1 are average values with the standard deviation of the
average B22 values.
The solubility of lysozyme was estimated for some sucrose concentrations at which
B22 was measured, and the results are presented in Table 3.2. To measure the solubility,
lysozyme stock was prepared by adding lysozyme to ∼ 100 µL of buffer until the solutions turned turbid. This solution was stirred on a magnetic stirrer for at least 1 hr and then
incubated at 25◦ C for 48 hrs. The stock solution was than transferred into a centrifuge
tube and spun down at 6,000 rpm for 20 minutes. Then 30 µL - 50 µL of supernatant was
removed and diluted with buffers, and its concentration was measured spectrophotomet-
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Table 3.1
B22 for Lysozyme in Buffer Containing Sucrose

[Sucrose] M B22 × 104 (mol.mL/g2 )

0.0

-7.2 ± 0.7

0.1

-4.9 ± 0.5

0.2

-3.5 ± 0.3

0.3

-2.6 ± 0.6

0.4

-1.4 ± 0.4

0.5

-0.7 ± 0.7
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rically. The obtained concentration values are the solubility values of the protein in that
particular solution, and are reported in Table 3.2.

Table 3.2
Solubility of Lysozyme at 25◦ C in Buffer Containing Sucrose

[Sucrose] M Solubility (mg/mL)

0.0

4.5

0.1
0.2

9.3

0.3
0.4

12.9

0.5

18.5

An increase in solubility and B22 values was found with increase in sucrose concentration. Figure 3.6 shows a plot of lysozyme solubility versus obtained B22 values. The
dashed line here does not imply any kind of theoretical fit but is a suggestive line.
The results obtained agree with the trend observed by George et al. [6, 9]. According to
those results, solubility follows the trends shown by B22 values. If B22 increases, solubility
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also increases and vice versa. The results in Figure 3.5 are consistent with the findings
[9, 10, 25].

3.1.2 B22 and Solubility Measurement for Lysozyme in Buffer Containing Trehalose
The second virial coefficient B22 of lysozyme was measured in 0.1 M NaAc, 5
% (w/v) NaCl, pH 4.5 with and without trehalose, and the obtained values are listed in
Table 3.3. The listed B22 values are average values of at least two SLS experiments along
with the standard deviation of the average B22 values. With the addition of trehalose, an
increase in B22 values was observed. Figure 3.7 shows

Kc
R

versus lysozyme concentration

in 0.1 M NaAc, 5 % (w/v) NaCl, pH 4.5, 25◦ C at 0.0, 0.1, 0.2, 0.3, 0.4, and 0.5 M trehalose.
B22 values obtained were determined from the slopes of the plots in Figure 3.7. With the
addition of trehalose the slope of the lines becomes less negative, and so do B22 values.
B22 values obtained increased with the increasing trehalose concentration, ranging
from −7.2 × 10−4 at 0.0 M trehalose to −0.7 × 10−4 (mol.mL/g2 ) at 0.5 M trehalose. At
0.0 M trehalose, a B22 value of −7.2×10−4 (mol.mL/g2 ) suggests that the protein-protein
interactions are attractive, while addition of trehalose increases B22 values to −0.7 × 10−4
(mol.mL/g2 ), which means that the protein-protein interactions have become less attractive. A plot of B22 versus trehalose concentration is shown in Figure 3.8.
The data points in Figure 3.8 represent average B22 values obtained from at least two
SLS experiments, and error bars represent the standard deviation of the average B22 values.
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Table 3.3
B22 for Lysozyme in Buffer Containing Trehalose

[Trehalose] M B22 × 104 (mol.mL/g2 )

0.0

-7.2 ± 0.7

0.1

-5.6 ± 0.3

0.2

-4.5 ± 0.1

0.3

-3.3 ± 0.2

0.4

-1.7 ± 0.1

0.5

-0.8 ± 0.0
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The solubility of lysozyme was estimated at each trehalose concentration at which B22
values were measured, and the results are presented in Table 3.4.

Table 3.4
Solubility of Lysozyme at 25◦ C in Buffer containing Trehalose

[Trehalose] M Solubility (mg/mL)

0.0

4.5

0.1

5.6

0.2

8.1

0.3

10.4

0.4

14.3

0.5

19.5

An increase in solubility and B22 value was measured with increase in trehalose concentration. Figure 3.8 shows a plot of lysozyme solubility versus obtained B22 values. The
dashed line here does not imply any kind of theoretical fit but is a suggestive line.
The results obtained agree with the trend observed by George et al [8]. According to
those results solubility follows the trends shown by B22 values [9, 10, 25].
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3.1.3 B22 and Solubility Measurement of Lysozyme in Buffer Containing Mannitol
The second virial coefficients B22 were measured at varying mannitol concentration in 0.1 M NaAc, 5 % (w/v) NaCl, pH. 4.5. Figure 3.10 shows the

Kc
R

versus lysozyme

concentration at 0.0, 0.05, 0.2, and 0.3 M mannitol. The tabulated B22 values were calculated from the slopes of the plots in Figure 3.10. B22 values obtained increased with
increasing mannitol concentration ranging from −7.2 × 10−4 (mol.mL/g2 ) at 0.0 M mannitol to −1.5 × 10−4 (mol.mL/g2 ) at 0.3 M mannitol. Addition of mannitol increases
B22 values to −1.5 × 10−4 (mol.mL/g2 ), which means that the protein-protein interactions has become less attractive. A plot of B22 versus mannitol concentration is shown in
Figure 3.11.
The data points in Figure 3.11 represent average B22 values obtained from at least two
SLS experiments, and error bars represent the standard deviation of the average B22 values.
B22 values listed in Table 3.5 are average values with the standard deviation of the
average B22 values.
The solubility of lysozyme was estimated for some mannitol concentrations at which
B22 values were measured, and the results are presented in Table 3.6. The procedure for
estimating the solubility was the same as that used for estimating solubility of lysozyme
in sucrose.
An increase in solubility and B22 was measured with increase in mannitol concentration. Figure 3.12 shows a plot of lysozyme solubility versus obtained B22 values. The
dashed line here does not imply any kind of theoretical fit but is a suggestive line.
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Table 3.5
B22 for Lysozyme in Buffer containing Mannitol

[Mannitol] M B22 × 104 (mol.mL/g2 )

0.00

-7.1 ± 0.7

0.05

-6.6 ± 0.4

0.20

-2.7 ± 0.0

0.25

-2.3 ± 0.1

0.30

-1.5 ± 0.0

Table 3.6
Solubility of Lysozyme at 25◦ C in Buffer containing Mannitol

[Mannitol] M Solubility (mg/mL)

0.00

4.5

0.05

4.5

0.20

6.7

0.25

7.8

0.30

-
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3.2

B22 Measurement for Ovalbumin Monomer
Commercial ovalbumin was analyzed by DLS to verify the presence of high molec-

ular weight impurities other than monomer. It was difficult to run DLS experiments, due to
automatic detector shut down caused due to the presence of high molecular weight species.
This suggested the presence of larger species like oligomers, aggregates, or dust particles.
Ovalbumin stock at ∼ 30 to 35 mg/mL prepared in 0.1 M sodium phosphate buffer,
pH 7.0 was loaded on a Superdex 75 HR (16 mm × 160 mm) size exclusion column
(Pharmacia Biotech) connected to a BioCad SPRINT perfusion chromatography system
and eluted with 0.1 M sodium phosphate, pH 7.0 mobile phase at a flow rate of 1.5 mL/min.
The elution profile of ovalbumin is shown in Figure 3.13.
Peak A is ovalbumin monomer, which was confirmed by DLS, while peaks B and C
may be lower order oligomers such as dimers or trimers. Peaks B and C were not collected
due to our interest in ovalbumin monomer only. Peak D that eluted first can be attributed
to high molecular weight impurities.
The monomer fraction was collected and concentrated using an Amicon 8010 concentrator with a Millex Millipore membrane, 42 mm, molecular weight cut off 3000 g/mol.
Purified monomer was analyzed using DLS to verify molecular size homogeneity. The
average hydrodynamic radius was 2.6 nm and the molecular weight estimated was ∼ 45
kDa calculated using Eq. (3.1-3.4). The final stock concentration after concentrating was
∼ 9.6 mg/mL.
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Figure 3.13
Elution profile of ovalbumin, A- ovalbumin monomer (45 kDa), B and C - lower order
oligomers and D- high molecular weight impurities
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The DLS histogram for the purified ovalbumin monomer is shown in Figure 3.13. DLS
showed the presence of one species at Rh = 2.6 nm, while some high molecular weight
impurities like dust are present.
The second virial coefficient B22 for ovalbumin was measured in 0.1 M sodium phosphate buffer, pH 7.0, containing varying amount of sucrose. The obtained values are listed
in Table 3.7. The listed B22 values are average B22 values along with the calculated standard deviation of the average B22 values. Figure 3.15 shows

Kc
R

versus ovalbumin con-

centration in 0.1 M sodium phosphate buffer, pH 7.0 at 0, 5, 10, 15, 20, and 25 % w/v
sucrose. B22 values listed in Table 3.7 were determined from the slope of the plots in Figure 3.15. The slopes become more positive as the sucrose concentration increases, and so
does B22 . With increasing concentration of sucrose, B22 values changed from −1.6 × 10−4
(mol.mL/g2 ) at 0 % w/v sucrose at which the protein-protein interactions are slightly
attractive to 7.3 × 10−4 (mol.mL/g2 ) at 25 % w/v sucrose when the protein-protein interactions turn repulsive.
A plot of B22 versus sucrose concentration for ovalbumin monomer is shown in Figure 3.16. The data points on the plot represent average B22 values, and error bars represent
the standard deviation of the average B22 values. The values obtained here agree completely with the values obtained in literature [2].
The relative solubility of ovalbumin as a function of sucrose concentration was obtained from the literature [2]. The purpose here is to obtain B22 values and solubility data
of ovalbumin to show that solubility follows the trend shown by B22 values. In this case,
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Figure 3.14
DLS histogram of ovalbumin
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54
addition of sucrose increases B22 values, and the same trend is observed for the solubility
Figure 3.17.

Table 3.7
Measured B22 for Ovalbumin monomer in Buffer Containing Sucrose

[Sucrose] M B22 × 104 (mol.mL/g2 )

0

-1.6 ± 0.0

5

-0.5 ± 0.0

10

1.1 ± 0.5

15

2.3 ± 0.2

20

5.7 ± 0.0

25

7.3 ± 0.4

3.3 B22 Measurement for Human Serum Albumin (HSA)
Human serum albumin was checked for molecular homogeneity using dynamic
light scattering. DLS were ambiguous for HSA due to the solution consisting of higher
molecular weight impurities.
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A stock solution containing ∼ 30 to 35 mg/mL HSA was prepared in 0.1 M sodium
phosphate buffer, pH 7.6. About 1 mL of the stock was injected in a Superdex 200 HR
(16 mm × 160 mm) size exclusion column (Pharmacia Biotech) connected to BioCad
SPRINT perfusion chromatography system and eluted with 0.1 M sodium phosphate, pH
7.6 mobile phase at a flow rate of 1.5 mL/min. The elution profile of HSA is shown in
Figure 3.18.
Peak A is HSA monomer, which was confirmed by DLS, while peak B may be lower
order oligomers such as dimers. Peak C that eluted first can be attributed to high molecular
weight impurities. Peaks B and C were not collected due to our interest in HSA monomer
only.
The monomer fractions were collected and concentrated using an Amicon 8010 concentrator with a Millex Millipore membrane, 42 mm, with Molecular weight cut off 3000
g/mol. Purified monomer was analyzed using DLS to verify molecular size homogeneity.
The average hydrodynamic radius was 2.9 nm, and the estimated molecular weight was ∼
68 kDa using Eq. (3.1-3.4). The final stock concentration determined spectrophotometrically after concentrating was ∼ 55 mg/mL.
The DLS histogram for the purified HSA monomer is shown in Figure 3.19. DLS
showed presence of one species at Rh = 2.9 nm.

3.3.1 B22 Measurement for HSA in Buffer Containing Glucose
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Figure 3.18
Elution profile of human serum albumin, A: HSA monomer (68 kDa), B: oligomers and
C: higher molecular weight impurities
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Figure 3.19
DLS histogram of the purified HSA
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The second virial coefficient B22 for HSA was measured in 0.1 M sodium phosphate
buffer, 2.6 M AS, pH 7.6, containing varying amounts of glucose. The obtained B22
values are listed in Table 3.8. The listed B22 values are average B22 values along with the
calculated standard deviation of the average B22 values. Figure 3.20 shows

Kc
R

versus HSA

concentration, c, in 0.1 M sodium phosphate buffer, 2.6 M AS, pH 7.6 at 0, 20, 40, and 80
mg/mL glucose. B22 values listed in Table 3.8 were determined from the slope of the plots
in Figure 3.20. The slopes become more positive as the glucose concentration increases,
and so does B22 .
With increasing glucose concentration, B22 values changed from −7.8 × 10−4 at 0
mg/mL glucose to −3.0 × 10−4 (mol.mL/g2 ) at 80 mg/mL glucose. The B22 values
measured for HSA monomer with varying glucose concentrations are listed in Table 3.8.

Table 3.8
Measured Solubility and B22 for HSA Monomer in Buffer containing Glucose

[Glucose] (mg/mL) Solubility (mg/mL) B22 × 104 (mol.mL/g2 )

0

2.2

-7.8 ± 0.2
-6.5 ± 0.1

20
40

39.0

-5.4 ± 0.0

80

≥55.0

-3.0 ± 0.3
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B22 versus glucose concentration for HSA in 2.6 M AS, and 0.1 M sodium phosphate, pH
7.6
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3.3.2 B22 Measurement for HSA in Buffer Containing Dextran150
B22 for HSA was measured in 0.1 M sodium phosphate, 1.65 M AS, pH 7.6 at 0,
10, and 20 mg/mL dextran150 concentration. The average molecular weight of dextran150
is around 150,000 g/mol. In the presence of 0 mg/mL dextran150, B22 was found to be
−0.4 × 10−4 (mol.mL/g2 ), which decreased at 20 mg/mL dextran150 to −3.3 × 10−4
(mol.mL/g2 ).
The

Kc
R

versus HSA concentration is shown in Figure 3.22. B22 values tabulated in

Table 3.8 are calculated from the slopes of the

Kc
R

versus HSA concentration plots. The

tabulated values are average values of at least duplicate sets of experiment, and together
are the standard deviation of the average B22 values. A plot of B22 versus dextran150
concentration is shown in Figure 3.23.
The B22 values measured for HSA monomer in 0.1 M sodium phosphate, 1.65 M AS,
pH 7.6 with varying dextran 150 concentrations are listed in Table 3.8.
Solubility values of HSA in dextran150 were obtained from the literature [3]. We
found that B22 values decreased with increasing dextran150 concentration, and the same
was true for solubility. This effect can be attributed to the big size of dextran150. As dextran150 concentration increases, the excluded volume available for the protein molecules
decreases. Consequently, the protein molecules precipitate out of the solution, causing
a decrease in the protein solubility. This phenomenon is also responsible for increased
protein-protein interactions, which is reflected in B22 , as they become more negative with
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Figure 3.22
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versus HSA concentration, c, at varying dextran150 concentration in 0.1 M sodium
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Relative solubility (%) for HSA versus B22 in 0.1 M sodium phosphate, 1.65 M AS, pH
7.6 at varying dextran150 concentration [3]
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Table 3.9
B22 for HSA at varying dextran150 concentration

[Dextran150] (mg/mL)

B22 × 104 (mol.mL/g2 )

0

-0.4 ± 0.0

10

-1.7 ± 0.1

20

-3.3 ± 0.2

addition of dextran150. A plot of HSA relative solubility versus B22 in buffer at varying
dextran150 concentration is shown in Figure 3.24.

CHAPTER IV
SUMMARY AND CONCLUSIONS
Static light scattering (SLS) was used to measure B22 of lysozyme, human serum albumin, and ovalbumin in buffer solutions containing various excipients. B22 values for
lysozyme was measured in 0.1 M NaAc, 5 % w/v NaCl, pH 4.5 with 0.0, 0.1, 0.2, 0.3, 0.4,
and 0.5 M sucrose, 0.0, 0.1, 0.2, 0.3, 0.4, and 0.5 M trehalose, and 0.0, 0.05, 0.2, 0.25,
and 0.3 M mannitol at 25◦ C. B22 obtained for lysozyme in 0.1 M NaAc, 5 % (w/v) NaCl,
pH 4.5 was −7.2 × 10−4 (mol.mL/g2 ). Addition of salt shields the charge on the protein
molecules, reduces long-range repulsive interactions, and increases hydrophobic effects.
Small salt molecules penetrate the protein molecules, causing unfolding of the molecule,
and exposing the protein hydrophobic patches. Since this is a thermodynamically highenergy state, the protein molecules come together, and join by hydrophobic patches, resulting into aggregation. B22 obtained suggests that the protein-protein interactions are
attractive. Addition of sucrose changes B22 to −0.7 × 10−4 (mol.mL/g2 ) at 0.5 M sucrose
concentration. B22 is still slightly negative, and the addition of sucrose shields one-protein
molecule from other, and increases the hydration of the protein molecules, causing reduction in hydrophobic effects. Since the hydration around the protein molecules increase,
the protein solubility is also increased. B22 values suggest that addition of sucrose makes
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the protein-protein interactions less attractive at 0.5 M sucrose concentration. Similar effects were observed on addition of trehalose and mannitol. B22 values of −0.9 × 10−4
(mol.mL/g2 ) and −1.0 × 10−4 (mol.mL/g2 ) were observed at 0.5 M trehalose concentration and 0.3 M mannitol concentration respectively. The results obtained are in agreement
with B22 values obtained by self-interaction chromatography (SIC) [5].
In the solubility study, the solubility of lysozyme was measured in the above-mentioned
buffers. In the solution with a B22 of −7.2 × 10−4 (mol.mL/g2 ) lysozyme solubility of
4.5 mg/mL was obtained, while a solubility of 9.3 mg/mL was observed at 0.2 M sucrose
concentration, and 18.5 mg/mL at 0.5 M sucrose concentration. For trehalose, solubility
ranged from 5.6 mg/mL at 0.1 M trehalose concentration to 19.5 mg/mL at 0.5 M trehalose
concentration. Solubility of lysozyme in buffer containing mannitol was 4.5 mg/mL at
0.05 M mannitol that changed to 7.8 mg/mL at 0.25 M mannitol concentration.
The measured B22 for ovalbumin in the presence of sucrose in 0.1 M sodium phosphate, pH 7.0 buffer was found to be −1.7 × 10−4 (mol.mL/g2 ) at 0 % w/v sucrose concentration and 7.3 × 10−4 (mol.mL/g2 ) at 25 % w/v sucrose concentration. These results
are in agreement with the values in available literature [2]. Since measuring solubility
is difficult, solubility values available in literature were used [2]. These results showed
that with increasing sucrose concentration both B22 and solubility of the protein increased.
At 25 % w/v sucrose concentration the protein-protein interactions become repulsive, and
solution becomes colloidally stable.
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The relative solubility of human serum albumin in presence of glucose in 0.1 M sodium
phosphate, 2.6 M AS, pH 7.6, and in presence of dextran150 in 0.1 M sodium phosphate, 1.65 M AS, pH 7.6 were obtained from literature [3]. Solubility of HSA increased
in glucose, which can also be predicted from increasing B22 values, which turned out
to be −7.8 × 10−4 (mol.mL/g2 ) at 0 mg/mL glucose concentration, and −3.0 × 10−4
(mol.mL/g2 ) at 80 mg/mL glucose. While with dextran150, B22 values were found to
be decreasing with increasing dextran150 concentration, as did the solubility. A B22 of
0.4 × 10−4 (mol.mL/g2 ) was determined at 0 mg/mL dextran150, which decrease to
−3.3 × 10−4 (mol.mL/g2 ). The solubility values correspond well with B22 . The increased solubility with increasing excipient concentration can be attributed to the fact that
excipients are preferentially excluded from the protein surface increasing the amount of
water in the vicinity of the protein molecule, resulting in increased solubility.
Measuring solubility is very time consuming, and none of the methods used for determining solubility are efficient enough to predict accurate solubility value. But as seen
in this study, solubility behavior of the proteins in buffer containing cosolvents can be
predicted from B22 . The Haas-Drenth-Wilson model [10], used to predict solubility for
the crystalline phase cannot be used to determine solubility in such cases, because this
model does not account for the stabilizing, or destabilizing effect of the added excipients.
An increase in B22 with the addition of cosolvents makes the protein-protein interactions
repulsive, and increases the solubility. An increase in solubility by itself is enough to assert that excipients like sucrose, trehalose, mannitol, and glucose stabilize the protein in a
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buffer solution. These excipients increase colloidal stability of the solution. An excipient
like dextran150, which decreases B22 and solubility, has a destabilizing effect. It decreases
colloidal stability, and at high enough concentration can cause precipitation of the protein
molecules from the solution. B22 has been used to predict the solubility behavior when
conditions are crystallizing. But from this study it can be said that they can also be used
to predict solubility behavior in stabilizing conditions.
A correlation exists between B22 , S, and stability of the protein in a solution. B22 can
be used to predict solubility, which in turn can be used to predict colloidal stability. Thus
B22 is not only predictor of solubility behavior, it also predicts the protein stability. In
future, this correlation can be used by pharmaceutical companies to measure the colloidal
stability, and predict solubility of the proteins in the solution.
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